Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 29 September, 2025
    MEDIA RELEASE MELBOURNE, VIC – We’re pleased to share that Redenlab has been awarded $2.5 million in non-dilutive funding through...
    • Posted on 25 July, 2025
      A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for people with ataxia-telangiectasia (A-T),...
      • Posted on 21 July, 2025
        Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of Alzheimer’s risk? Our new...